论文部分内容阅读
目的观察麝香保心丸联合酒石酸美托洛尔治疗室性早搏的疗效。方法选择诊断明确的室性早搏患者98例,分为治疗组50例和对照组48例,对照组给予酒石酸美托洛尔治疗。治疗组除给予酒石酸美托洛尔外,加用麝香保心丸。15d后分别测心电图及动态心电图,观察临床疗效及安全性。结果治疗组临床症状明显改善。显效率、总有效率与对照组比较差异有统计学意义(P<0.05)优于对照。结论麝香保心丸联合酒石酸美托洛尔治疗室性早搏疗效肯定,安全,优于常规酒石酸美托洛尔抗心律失常治疗,值得临床推广应用。
Objective To observe the efficacy of Shexiang Baoxin Pill combined with metoprolol tartrate in the treatment of ventricular premature beats. Methods Ninety-eight patients with definite premature ventricular contractions were selected and divided into treatment group (50 cases) and control group (48 cases). The control group was given metoprolol tartrate treatment. In addition to the treatment group was given metoprolol tartrate, add musk heart pill. Fifteen days after were measured electrocardiogram and Holter, observe the clinical efficacy and safety. Results The clinical symptoms of the treatment group improved significantly. Significant efficiency, total effective rate compared with the control group was statistically significant (P <0.05) better than the control. Conclusions Shexiang Baoxin Pill combined with metoprolol tartrate in the treatment of ventricular premature beats is effective and safe, which is superior to the conventional anti-arrhythmia treatment of metoprolol tartrate. It is worthy of clinical application.